INPLASY202450022

The safety of PD-1 inhibitors combined with ADC drugs for tumor patients

Keywords: Immune Checkpoint Inhibitors, Antibody-Drug Conjugate, Tumor, Drug-Related Side Effects and Adverse Reactions.

Download PDF - 202450022

Review Status: Ongoing